Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

[Profitability of a day hospital: analysis of activity, cost and effectiveness].

Hernando Ortiz L, Hinojosa Mena-Bernal C, González Sarmiento E, González Guilabert I, Arana Ruiz J, Muñoz Moreno MF.

Gac Sanit. 2012 Jul-Aug;26(4):360-5. doi: 10.1016/j.gaceta.2011.09.034. Epub 2012 Feb 23. Spanish.

2.

Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practice.

Macías J, González J, Ortega E, Tural C, Cabrero E, Burgos A, Pineda JA; GRAFIHCO Study Team.

HIV Med. 2010 Aug;11(7):439-47. doi: 10.1111/j.1468-1293.2009.00812.x. Epub 2010 Feb 17.

3.

Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients.

Pineda JA, González J, Ortega E, Tural C, Macías J, Griffa L, Burgos A; Grafihco Study Team.

J Viral Hepat. 2010 Oct;17(10):714-9. doi: 10.1111/j.1365-2893.2009.01229.x.

PMID:
20002560
4.

Patients' perception and effectiveness of a treatment containing enfuvirtide when used in HIV-infected patients without very advanced disease.

Pulido F, Del Pozo MA, Fernández-Guerrero M, Moreno A, Oteo JA, Flores J, Pedrol E, Torres R, Padilla B, Téllez MJ, García J, González-García J; ESPPE Study Group.

HIV Clin Trials. 2008 Mar-Apr;9(2):83-90. doi: 10.1310/hct0902-83.

PMID:
18474493

Supplemental Content

Loading ...
Support Center